Evidence map›Paper›PMID 22697294›Full record

ArticleCutaneous and ocular toxicology2013

The effect of physiologic aqueous solutions on the perovskite material lead-lanthanum-zirconium titanate (PLZT): potential retinotoxicity.

William J Foster, James K Meen, Donald A Fox

Open access · greenAbstract read
In one paragraph

Article in Cutaneous and ocular toxicology, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 17 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 3 institutions in 1 country.

William J FosterDepartment of Physics, The University of Houston, Houston, TX, USA.
James K Meen
Donald A Fox
Houston Methodist · USMethodist Hospital · USUniversity of Houston · US

Funding

Research Programming ModuleP30EY007551 · NEI · UNIVERSITY OF HOUSTON · PI GEUNYOUNG YOON · 1988 to 2026
$16.4M
Low-Level Prenatal Lead Exposure and Retinal ToxicityR01ES012482 · NIEHS · UNIVERSITY OF HOUSTON · PI FOX, DONALD A · 2003 to 2009
$1.7M
The application of nanotechnology to the retinaK08EY017112 · NEI · UNIVERSITY OF HOUSTON · PI FOSTER, WILLIAM JOSEPH · 2006 to 2010
$950k
NEI NIH HHS EY007551NEI NIH HHS EY017112NEI NIH HHS K08 EY017112NEI NIH HHS P30 EY007551NEI NIH HHS P30 EY07551NIEHS NIH HHS R01 ES012482
6 · The paper itself

Abstract

contextPerovskite compounds, including lead-lanthanum-zirconium titanate (PLZT), have wide technological application because of their unique physical properties. The use of PLZT in neuro-prosthetic systems, such as retinal implants, has been discussed in a number of publications. Since inorganic lead is a retinotoxic compound that produces retinal degeneration, the long-term stability of PLZT in aqueous biological solutions must be determined.

objectiveWe evaluated the stability and effects of prolonged immersion of a PLZT-coated crystal in a buffered balanced salt solution. MATERIALS AND

methodsScanning Electron Microscopy and Electron Dispersive Spectroscopy (EDS) using a JEOL JSM 5410 microscope equipped with EDS were utilized to evaluate the samples before and after prolonged immersion.

resultsWe found that lead and other constituents of PLZT leached into the surrounding aqueous medium. DISCUSSION: By comparing the unit cell of PLZT with that of CaTiO(3), which has been found to react with aqueous fluids, Lead is in the same site in PLZT as Ca is in CaTiO(3). It is thus reasonable that PLZT will react with aqueous solutions.

conclusionThe results suggest that PLZT must either be coated with a protective layer or is not appropriate for long-term in vivo or in vitro biological applications.

Indexed as

Calcium CompoundsLanthanumLeadOxidesProstheses and ImplantsRetinaSolutionsTitaniumZirconiumCalcium CompoundsLanthanumLeadOxidesperovskiteSolutionsTitaniumZirconium

Identifiers

PMID22697294
PMCPMC5094206
OpenAlexW2009421877

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.